Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

207
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
207
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

240
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
240
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

189
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
189
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

251
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

3.3K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.3K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Fifteen-minute update: International normalised ratio as the treatment end point in children with acute paracetamol poisoning.

Archives of disease in childhood. Education and practice edition·2021
Same author

Fifteen-minute consultation: Evaluation of paediatric torticollis.

Archives of disease in childhood. Education and practice edition·2021
Same author

NICE guidance on diagnosis and management of cystic fibrosis.

Archives of disease in childhood. Education and practice edition·2020
Same author

Atraumatic lumbar puncture needles are associated with fewer complications than conventional needles.

Archives of disease in childhood. Education and practice edition·2018
Same journal

Impact of antenatal biological response modifying drugs on infant infection risk and vaccination rates: a national cohort study.

Archives of disease in childhood·2026
Same journal

Draft charter for asthma in children and young people, inspired by Martha's rule.

Archives of disease in childhood·2026
Same journal

Declines in support for and use of corporal punishment of children in Aotearoa New Zealand over time: what a difference a law change makes.

Archives of disease in childhood·2026
Same journal

Mind the gap: comparing clinician and caregiver interpretation of reattendance events to the Children's Emergency Department.

Archives of disease in childhood·2026
Same journal

Puffy infant suffering from respiratory distress: a clue for visual diagnosis.

Archives of disease in childhood·2026
Same journal

Preparing for systematic tuberculosis screening of children and young people in a low-incidence setting: who should we target?

Archives of disease in childhood·2026
関連記事をすべて見る

関連する実験動画

Updated: Jan 13, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

427

小児科における品質改善

Sahana Rao1,2

  • 1Department of Paediatrics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK sahana.rao@ouh.nhs.uk.

Archives of disease in childhood
|January 6, 2026
PubMed
まとめ
この要約は機械生成です。

品質改善（QI）は、ヘルスケアサービスと患者の転帰を向上させるための体系的なアプローチを提供する。このレビューは、臨床医、特に小児科医が、より良い患者ケアのためにQIを日常業務に統合するための知識を身につけることを目的としている。

キーワード:
小児保健サービスデータ収集ヘルスケア経済学と組織小児科

さらに関連する動画

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

7.2K
Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.4K

関連する実験動画

Last Updated: Jan 13, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

427
A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

7.2K
Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.4K

科学分野:

  • ヘルスケアマネジメント
  • 患者の安全性
  • 臨床実践の改善

背景:

  • 品質改善（QI）は、安全で効率的で患者中心のヘルスケアに不可欠である。
  • QIには、サービスを改善するための体系的な問題解決と反復的なテストが含まれる。
  • 継続的な改善は、ヘルスケア提供を最適化するための鍵である。

研究 の 目的:

  • 品質改善の原則と方法論に関する臨床医の理解を深めること。
  • 小児科医が日常の臨床業務にQIの実践を統合することを奨励すること。
  • 小児医療におけるQIの包括的な概要を提供すること。

主な方法:

  • ヘルスケアにおける基本的なQIフレームワークとその応用のレビュー。
  • 患者の転帰に対するQIの影響を支持するエビデンスの分析。
  • 持続可能なQI実装のための課題と戦略の議論。

主要な成果:

  • QIは、ヘルスケアサービスを体系的に改善するための構造化されたアプローチを提供する。
  • エビデンスは、患者の安全性と転帰の向上におけるQIの変革的な役割を支持している。
  • QIの成功裏な統合には、特定の問題に対処し、戦略的なアプローチを採用する必要がある。

結論:

  • QIの理解と実装は、小児医療を進歩させるために重要である。
  • 小児科医は、患者ケアの継続的な改善を推進するためにQIを活用できる。
  • 品質イニシアチブを維持するには、戦略的な計画と実装障壁の克服が必要である。